欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
HR/H/0182/001
药品名称
Sevelamercarbonat Ratiopharm
活性成分
sevelamer carbonate 800.0 mg
剂型
Film-coated tablet
上市许可持有人
ratiopharm GmBH Graf-Arco-Str. 3, Ulm, 89079 Germany
参考成员国 - 产品名称
Croatia (HR)
互认成员国 - 产品名称
Portugal (PT)
许可日期
2015/02/12
最近更新日期
2023/05/18
药物ATC编码
V03AE02 sevelamer
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
Sevelamerkarbonat_Pliva_common_PL_ clean
Date of last change:2024/09/06
Final Product Information
|
Sevelamerkarbonat_Pliva_common_PL_TC
Date of last change:2024/09/06
Final Product Information
|
Sevelamerkarbonat_Pliva_common_SmPC_ clean
Date of last change:2024/09/06
Final Product Information
|
Sevelamerkarbonat_Pliva_common_SmPC_TC
Date of last change:2024/09/06
PubAR
|
Module 5 public summary and scientific discussion sevelamer carbonate DK_H_2298_001_DC
Date of last change:2024/09/06
Final Labelling
|
Sevelamer carbonate_DK_H_2298_001_OuP_ImP Bottle_12_09_19
Date of last change:2024/09/06
Final PL
|
Sevelamer carbonate_DK_H_2298_001_PIL_19_11_2019
Date of last change:2024/09/06
Final SPC
|
Sevelamer carbonate_DK_H_2298_001_SmPC_12_09_19
Date of last change:2024/09/06
PubAR Summary
|
Summary Public Assessment Report
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase